A) <100 mmHg B) <110 mmHg C) <90 mmHg D) <80 mmHg
A) 0.50% B) 0.01% C) 1.4% D) 0.14%
A) 16% B) 96% C) 69% D) 50%
A) 50 μg/L B) 100 μg/L C) 500 μg/L D) 1000 μg/L
A) Age plus 500 μg/L B) Age multiplied by 10 μg/L C) Age multiplied by 5 μg/L D) Age divided by 10 μg/L
A) 69% to 84% B) 16% to 47% C) 5% to 15% D) 50% to 60%
A) Erythrocyte sedimentation rate B) Right heart catheterization C) Leg ultrasound D) CT pulmonary angiography
A) It is rarely available B) It is less accurate than a blood count C) It is highly invasive D) It cannot rule out PE
A) It is significantly inferior B) It is non-inferior C) It is much more expensive D) It is less sensitive
A) It requires right heart catheterization B) It is always done before D-dimer C) It may identify other lung disorders D) It has 100% specificity
A) 69% B) 83% C) 96% D) 50%
A) It has limited sensitivity B) It requires contrast agent C) It has 0% specificity D) It is too expensive
A) To measure lung function B) To definitively confirm PE C) To provide evidence for the need for imaging D) To replace the need for CTPA entirely
A) D-dimer only B) Troponin only C) Full blood count and clotting status D) Blood pressure only
A) Age bias B) Selection bias C) Incorporation bias D) Measurement bias
A) 69% B) 50% C) 83% D) 96%
A) Red blood cell count B) Blood glucose levels C) Vitamin D levels D) Factor V Leiden mutation
A) Greater than 120 beats per minute B) Less than 100 beats per minute C) Exactly 150 beats per minute D) Between 100 and 110 beats per minute
A) Less than 80% B) More than 94% C) Between 85% and 90% D) Exactly 90%
A) No coughing up blood B) No leg swelling C) No history of surgery D) Estrogen use
A) To replace the need for clinical history B) As a screening test for everyone C) To diagnose lung cancer D) As a confirmatory test
A) 41% B) 96% C) 80% D) 10%
A) Clinical reasoning B) Patient preference alone C) The time of day D) Hospital policy only
A) No leg swelling B) Age less than 50 C) A history of trauma in the last year D) No previous blood clots
A) Distal calf DVT B) Superficial venous thrombosis C) Iliofemoral DVT D) Portal vein thrombosis
A) Athletes with chronic dehydration B) Young men without significant risk factors C) Elderly women with cancer D) Children with genetic disorders
A) Venous thromboembolism B) Chronic venous insufficiency C) Pulmonary hypertension syndrome D) Arterial thrombosis
A) The VTE framework B) The hypercoagulable model C) The clotting cascade D) Virchow's triad
A) Dental surgery B) Orthopedic surgery at or below the hip C) Tonsillectomy D) Ocular surgery
A) Factor V Leiden B) Antiphospholipid syndrome C) Protein S deficiency D) Protein C deficiency
A) Antiphospholipid syndrome B) Protein C deficiency C) Nephrotic syndrome D) Paroxysmal nocturnal hemoglobinuria
A) They decrease the blood viscosity B) They cause endothelial injury C) They cause systemic dehydration D) They stimulate procoagulant secretion
A) High-fiber diet B) Frequent exercise C) Prolonged bed rest D) Low altitude living
A) Troponin test B) Liver function test C) D-dimer D) White blood cell count
A) Aspirin B) Warfarin C) Acetaminophen D) Ibuprofen
A) Lung transplant B) Temporary vena cava filter C) Blood transfusion D) Chest tube insertion
A) Hemoptysis B) Tachypnea C) Cyanosis D) Dyspnea
A) Tissue plasminogen activator B) Direct-acting oral anticoagulants C) Warfarin D) Heparin
A) Nearly 90% B) Less than 1% C) About 15% D) 50%
A) The Geneva rule group B) The PIOPED investigators C) Philip Steven Wells D) The 64-slice MDCT researchers
A) Confirmed PE B) Moderate probability C) Low probability D) High probability
A) 2.0 points B) 1.5 points C) 1.0 points D) 3.0 points
A) 97.4% B) 21.9% C) 5.0% D) 1.0%
A) PERC rule B) Geneva rule C) Wells score D) PIOPED recommendation
A) Pregnant patients B) Patients with high blood pressure C) Patients with chronic obstructive pulmonary disease D) Elderly patients
A) Chest X-ray B) SPECT C) Fluoroscopy D) Planar two-dimensional imaging
A) Prolonged PR interval B) S1Q3T3 C) ST elevation in V5-V6 D) Left bundle branch block
A) Complete heart block B) Sinus tachycardia C) Inverted T waves in V1-V4 D) Atrial fibrillation
A) Atrial fibrillation B) QRS narrowing C) Sinus bradycardia D) Normal sinus rhythm
A) Antibiotic therapy B) Thrombolysis C) Beta-blocker administration D) Diuretic monotherapy
A) C-reactive protein B) Creatinine C) White blood cell count D) Brain natriuretic peptide
A) Diagnosing pneumonia B) Checking for pleurisy C) Prognosis assessment D) Determining lung volume
A) Virchow's sign B) Trousseau's sign C) McConnell's sign D) Homan's sign
A) 77% B) 94% C) 25% D) 50%
A) No B) Yes C) Only if they are under 18 years old D) Only if they are asymptomatic
A) Glucose B) Troponins C) Albumin D) Hemoglobin
A) Long-term aspirin therapy B) Surgical removal of the embolus C) Anticoagulant therapy D) Bed rest and elevation
A) Warfarin B) Aspirin C) Heparin D) Fondaparinux
A) Aspirin B) Dabigatran C) Warfarin D) LMWH
A) 1 month B) 10–12 months C) 1 week D) 3–6 months
A) 6 months B) 2 years C) 10 years D) 1 month
A) Itching B) Hypotension C) Mild headache D) Increased appetite
A) 10% B) 50% C) 5% D) 26%
A) Cambridge Medical Center B) Bristol Royal Infirmary C) Oxford University Hospital D) London General Hospital
A) Type 1 diabetes B) COPD C) Thyroid disease D) Allergies
A) Old technology detected only severe PEs B) The sample size was too large C) The patients were all children D) The data was fabricated
A) Low hemoglobin B) High blood glucose C) Increased white blood cell count D) Elevated cardiac enzymes
A) Radiation B) Fibrinolysis C) Surgery D) Osmosis
A) 10 B) 11 C) 15 D) 5
A) 40,000 B) 100,000 C) 10,000 D) 250,000 |